Lupin Limited (LUPIN) - Total Liabilities
Based on the latest financial reports, Lupin Limited (LUPIN) has total liabilities worth Rs137.72 Billion INR (≈ $1.49 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Lupin Limited - Total Liabilities Trend (2004–2025)
This chart illustrates how Lupin Limited's total liabilities have evolved over time, based on quarterly financial data. See LUPIN working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Lupin Limited Competitors by Total Liabilities
The table below lists competitors of Lupin Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
WinWay Technology Co. Ltd
TW:6515
|
Taiwan | NT$1.98 Billion |
|
Revvity Inc.
NYSE:RVTY
|
USA | $4.81 Billion |
|
Hyundai Glovis
KO:086280
|
Korea | ₩9.45 Trillion |
|
Shenzhen Kinwong Electronic Co Ltd
SHG:603228
|
China | CN¥11.87 Billion |
|
Evolution Gaming Group AB (publ)
F:E3G
|
Germany | €1.55 Billion |
|
Grupo Aeroportuario del Pacifico SAB De CV ADR
NYSE:PAC
|
USA | $72.32 Billion |
|
DIETEREN GR. UNSP.ADR 1/2
F:DJD
|
Germany | €6.17 Billion |
|
AB SKF (publ)
ST:SKF-B
|
Sweden | Skr52.19 Billion |
Liability Composition Analysis (2004–2025)
This chart breaks down Lupin Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see LUPIN stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.87 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.28 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.70 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.41 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Lupin Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Lupin Limited (2004–2025)
The table below shows the annual total liabilities of Lupin Limited from 2004 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs119.11 Billion ≈ $1.29 Billion |
+23.76% |
| 2024-03-31 | Rs96.24 Billion ≈ $1.04 Billion |
-7.58% |
| 2023-03-31 | Rs104.13 Billion ≈ $1.13 Billion |
+8.48% |
| 2022-03-31 | Rs95.99 Billion ≈ $1.04 Billion |
-1.57% |
| 2021-03-31 | Rs97.52 Billion ≈ $1.05 Billion |
-21.37% |
| 2020-03-31 | Rs124.03 Billion ≈ $1.34 Billion |
-12.41% |
| 2019-03-31 | Rs141.60 Billion ≈ $1.53 Billion |
+11.60% |
| 2018-03-31 | Rs126.88 Billion ≈ $1.37 Billion |
-2.96% |
| 2017-03-31 | Rs130.75 Billion ≈ $1.41 Billion |
+14.40% |
| 2016-03-31 | Rs114.29 Billion ≈ $1.24 Billion |
+169.59% |
| 2015-03-31 | Rs42.40 Billion ≈ $458.49 Million |
+32.18% |
| 2014-03-31 | Rs32.08 Billion ≈ $346.88 Million |
-12.13% |
| 2013-03-31 | Rs36.50 Billion ≈ $394.76 Million |
-6.33% |
| 2012-03-31 | Rs38.97 Billion ≈ $421.45 Million |
+39.59% |
| 2011-03-31 | Rs27.92 Billion ≈ $301.92 Million |
+12.02% |
| 2010-03-31 | Rs24.92 Billion ≈ $269.52 Million |
-7.53% |
| 2009-03-31 | Rs26.95 Billion ≈ $291.46 Million |
+29.90% |
| 2008-03-31 | Rs20.75 Billion ≈ $224.37 Million |
+49.29% |
| 2007-03-31 | Rs13.90 Billion ≈ $150.29 Million |
-2.06% |
| 2006-03-31 | Rs14.19 Billion ≈ $153.45 Million |
+64.28% |
| 2005-03-31 | Rs8.64 Billion ≈ $93.40 Million |
+8.17% |
| 2004-03-31 | Rs7.98 Billion ≈ $86.35 Million |
-- |
About Lupin Limited
Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India, the United States, and internationally. The company operates in two segments: Pharmaceuticals and Others. It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars, over-the-counter and specialty drugs, and active pharmaceutica… Read more